Royal London Asset Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-8,343
| Closed | -$361K | – | 729 |
|
2025
Q1 | $361K | Buy |
+8,343
| New | +$361K | ﹤0.01% | 705 |
|
2024
Q3 | – | Sell |
-72,611
| Closed | -$3.07M | – | 642 |
|
2024
Q2 | $3.07M | Buy |
72,611
+2,303
| +3% | +$97.3K | 0.01% | 595 |
|
2024
Q1 | $4.86M | Sell |
70,308
-110
| -0.2% | -$7.6K | 0.01% | 553 |
|
2023
Q4 | $5.21M | Buy |
70,418
+2,040
| +3% | +$151K | 0.01% | 531 |
|
2023
Q3 | $4.66M | Buy |
68,378
+3,983
| +6% | +$272K | 0.02% | 525 |
|
2023
Q2 | $6.04M | Buy |
64,395
+2,826
| +5% | +$265K | 0.02% | 464 |
|
2023
Q1 | $4.17M | Buy |
61,569
+827
| +1% | +$56.1K | 0.02% | 514 |
|
2022
Q4 | $3.01M | Buy |
60,742
+2,950
| +5% | +$146K | 0.01% | 566 |
|
2022
Q3 | $1.88M | Sell |
57,792
-4,293
| -7% | -$140K | 0.01% | 601 |
|
2022
Q2 | $2.45M | Buy |
62,085
+1,152
| +2% | +$45.4K | 0.01% | 584 |
|
2022
Q1 | $4.26M | Buy |
60,933
+2,832
| +5% | +$198K | 0.02% | 534 |
|
2021
Q4 | $4.52M | Sell |
58,101
-1,109
| -2% | -$86.4K | 0.02% | 519 |
|
2021
Q3 | $5.65M | Sell |
59,210
-3,202
| -5% | -$306K | 0.02% | 462 |
|
2021
Q2 | $7.75M | Buy |
62,412
+7,942
| +15% | +$987K | 0.03% | 391 |
|
2021
Q1 | $7.18M | Buy |
54,470
+1,095
| +2% | +$144K | 0.03% | 376 |
|
2020
Q4 | $7.08M | Sell |
53,375
-1,134
| -2% | -$150K | 0.04% | 347 |
|
2020
Q3 | $5.56M | Buy |
54,509
+525
| +1% | +$53.5K | 0.03% | 376 |
|
2020
Q2 | $4.64M | Hold |
53,984
| – | – | 0.03% | 403 |
|
2020
Q1 | $3.15M | Hold |
53,984
| – | – | 0.03% | 462 |
|
2019
Q4 | $4.96M | Buy |
53,984
+8,298
| +18% | +$762K | 0.03% | 431 |
|
2019
Q3 | $4.13M | Buy |
+45,686
| New | +$4.13M | 0.03% | 465 |
|